II. Epidemiology: Symptom Prevalence
- Asthenia (Fatigue): 90%
- Anorexia: 85%
- Cancer Pain: 76%
- Nausea: 68%
- Constipation: 65%
- Sedation or confusion: 60%
- Dyspnea: 12%
III. Management: Approach
- Target the underlying cause of symptoms (e.g. treat the Dyspnea leading to anxiety)
- Medication initiation and titration- Start medications at low dose and titrate to effect
- Transition as needed dosing to scheduled dosing and to longer acting agents
- Proactively prevent symptoms if possible
 
- Medication delivery- Consider alternative formulations that allow for difficult patient Swallowing and Somnolence
- Some medications may be reformulated by compounding pharmacies
- Sublingual medications (mucous membranes must be moist)
- Concentrated and dissolving medications
- Transdermal patches, creams and gels
- Rectal suppositories
 
IV. Management: Cancer Emergencies
- Metabolic Cancer Complications
- Hematologic Complications
- Infectious and hematologic Cancer Complications
- Vascular Complications (structural emergencies resulting in obstruction)- Malignant Cardiac Tamponade- Pericardial Effusion is present in up to one third of cancer patients
- Most common cancer causes of Pericardial Effusion are metastatic lung and Breast Cancer
 
- Superior Vena Cava Syndrome
- Hyperviscosity Syndrome (includes Polycythemia Vera and Leukostasis)
- Venous Thromboembolism
 
- Malignant Cardiac Tamponade
- Neurologic complications
- Gastrointestinal complications- See gastrointestinal symptoms below
- Neutropenic Colitis (Neutropenic Enterocolitis, Typhlitis)
 
- Chemotherapy complications
- 
                          Radiation Therapy complications- See Radiation Therapy for adverse effects
 
- 
                          Cancer Immunotherapy complications- See Cancer Immunotherapy for adverse effects
- Serious complications include Pneumonitis and Pancreatitis
 
- References- Aurora and Herbert in Majoewsky (2013) EM:Rap 13(10): 1-4
- Long, Long and Koyfman (2020) Crit Dec Emerg Med 34(11): 17-24
- Higdon (2006) Am Fam Physician 74:1873-80 [PubMed]
- Zuckerman (2012) Blood 120(10): 1993-2002 [PubMed]
 
V. Management: Symptoms
- Mouth and Dental- Includes Dry Mouth and excessive oral secretions
- See Mouth Care in Cancer
 
- Dermatology- See Fungating Growths
- See Radiation Dermatitis
 
- Pain
- 
                          Dehydration in Cancer Patients- See Cachexia in Cancer
- See Hypodermoclysis
- Only treat if it improves quality of life
- Risk Intravenous Fluids: Iatrogenic Pulmonary Edema
 
- 
                          Hypercalcemia of Malignancy
                          - Most common serious Palliative Care metabolic effect
- Always keep in mind and test for it!
- Fluids effectively treat Hypercalcemia in most cases
 
- Gastrointestinal
- Pulmonary
- Neurologic and Psychiatric
- Rheumatology and Musculoskeletal- See Fatigue in Cancer
- Radicular symptoms should be evaluated with advanced imaging- Cancer patients may not present with typical red flag symptoms (e.g. cauda equina, bilateral involvement)
 
 
- Cerebral Edema- Treat with Dexamethasone (and concurrent H2 Blocker)
 
- Fluid Third Spacing- Malignant Ascites
- See Pleural Effusion in Cancer
 
VI. Management: Oncology Consultation or Referral
- Urgent Indications- New cancer diagnosis or significant progression of known cancer (for diagnostics and treatment)
- Oncology emergencies (see above)
- Cancer therapy complications (e.g. severe therapy adverse effects)
- Unclear treatment strategy in active cancer (aggressive treatment vs Palliative Care)
 
- Routine Indications- Chemotherapy adjustment or adjunctive management
- Coordination of cancer treatment with other, comorbid medical condition management
- Transitions of Care (e.g. emergency department or hospital discharge)
 
VII. Management: Disposition
- Hospital Admission Indications- Oncology emergencies (see above)
- Hemodynamic instability
- Severe, refractory Cancer Symptoms (e.g. intractable pain, respiratory distress)
- Complex management (e.g. multiple time-intensive interventions, high risk conditions)
- New or worsening significant neurologic symptoms (e.g. Spinal Cord Compression, Delirium)
- Socioeconomic barriers (e.g. no transportation, no support, Cognitive Impairment or Disability, remote home)
 
- Outpatient Management Indications (assumes oncology follow-up, consider Consultation)- Controllable cancer related symptoms (see above)
- Low risk Neutropenic Fever (consult oncology)
- Clinically stable
 
VIII. Management: Special Circumstances
- Terminal patients who choose not to eat or drink- Some patients will choose to hasten their own death
- Competent patients may refuse to take nourishment
- Study looked at suffering, pain and duration to death- Patients died within 2 weeks of stopping intake
- Low level of pain and suffering
- Ganzini (2003) N Engl J Med 349:359-65 [PubMed]
 
 
- Pill burden- Discontinue pills that do not affect quality of life (Antihypertensives, Hyperlipidemia agents, diabetes medications)
- Eliminate medications with significant adverse effects (e.g. Anticholinergic Medications cause Constipation)
 
IX. Management: Hospice Comfort Kit
- Antpyretics for fever- Acetaminophen 650 mg suppository SL or PR every 4 hours as needed for fever
 
- 
                          Opiates for pain, Shortness of Breath (caution: highly concentrated)- See Cancer Pain Opioid
- Morphine 20 mg/ml 5-10 mg (0.25 to 0.5 ml) every 3 hours as needed for pain, Shortness of Breath
- Oxycodone 20 mg/ml 5-10 mg (0.25 to 0.5 ml) every 3 hours as needed for pain, Shortness of Breath
 
- 
                          Benzodiazepines for anxiety- Lorazepam 2 mg/ml 0.5 to 1 mg SL or PR every 4 hours as needed for anxiety
 
- 
                          Antipsychotics for Nausea, Agitation- Haloperidol 2 mg/ml 0.5 to 1 mg SL or PR every 4 hours as needed for Nausea or Agitation
- Risperidone 2 mg/ml 0.5 to 1 mg SL or PR every 4 hours as needed for Nausea or Agitation
 
- 
                          Anticholinergics for excessive oral secretions- Hyoscamine 0.125 mg SL every 6 hours as needed for excessive oral secretions
- Atropine 1% ophthalmic drops SL every 6 hours as needed for excessive oral secretions
 
X. Resources
- End of Life Physicians Education Resource- http://www.eperc.mcw.edu
- Fast Facts offers an excellent clinician resource
 
- National Cancer Institute
- Center to Advance Palliative Care
- American Academy of Hospice and Palliative Medicine
XI. References
- Bierowski and Nyalakonda (2025) Crit Dec Emerg Med 39(6): 4-21
- Storey (1996) Primer of Palliative Care, AAHPM
- Albert (2017) Am Fam Physician 95(6): 356-61 [PubMed]
- Higdon (2018) Am Fam Physician 97(11):741-8 [PubMed]
- Ross (2001) Am Fam Physician 64(6):1019-26 [PubMed]
- Ross (2001) Am Fam Physician 64(5):807-14 [PubMed]
